In recent years, the U.S. Food and Drug Administration gave a green light for the use of dupilumab injections for eczema patients (6 years and above) who do not fare well with topical therapies.
Topical immunomodulators (TMIs)
Some data has pointed in the direction of topical immunomodulators (TMIs) to help combat the usual symptoms of eczema. TMIs regulate the skin’s immune response and are usually a viable treatment option for patients who have not responded to other modes of treatment.
Phototherapy
Many people who suffer from eczema have shown remarkable progress with phototherapy, which commonly employs the use of a machine that emits narrowband ultraviolet B (NB-UVB) light. Phototherapy is often used to treat eczema that has spread to many parts of the body.
Key Takeaway
Eczema is a chronic skin disease that affects millions of children and adults worldwide. Presently, there is no one-size-fits-all solution as to how to manage eczema permanently. Thankfully, a variety of treatment options are available that have been proven to alleviate, if not eliminate, the typical symptoms of this disease.
Learn more about managing eczema and dermatitis here.
Comments
Share your thoughts
Be the first to let Hello Doctor know your thoughts!
Join Us or Log In to join the discussion